Filing Details
- Accession Number:
- 0001567619-20-016945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-21 17:06:31
- Reporting Period:
- 2020-09-17
- Accepted Time:
- 2020-09-21 17:06:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1512762 | Coherus Biosciences Inc. | CHRS | Biological Products, (No Disgnostic Substances) (2836) | 273615821 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733375 | R Vincent Anicetti | Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-17 | 2,500 | $2.50 | 51,056 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-09-17 | 2,500 | $12.70 | 53,556 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-17 | 5,000 | $18.84 | 48,556 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-17 | 2,500 | $0.00 | 2,500 | $2.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-17 | 2,500 | $0.00 | 2,500 | $12.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,488 | 2024-06-30 | No | 4 | M | Direct | |
| 27,500 | 2027-08-06 | No | 4 | M | Direct |
Footnotes
- Includes 31,250 restricted stock units.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- The transaction was executed in multiple trades in prices ranging from $18.58 to $19.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- All of the shares underlying this option are vested and exercisable as of the date hereof.
Billionaire Hedge Funds
